MENU
QNCX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Quince Therapeutics (QNCX) Ownership - Who owns Quince Therapeutics?
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
53.65M
P/E Ratio
N/A
Total Cash
47.85M
Projected Growth
N/A
Total Debt
15.45M
Revenue
N/A
Risk (Beta)
0.78
Dividend Yield
N/A
Total Cash/Share
1.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
QNCX
Capitalization
53.7M
P/E Ratio
N/A
Risk (Beta)
0.78
Dividend Yield
N/A
Total Cash
47.8M
Total Cash/Share
1.05
Total Debt
15.4M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
44.9M
P/B Ratio
2.89
Cash Flow
N/A
Earnings
-1.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
43K
Current Ratio
9.53
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-33.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.27
Shares Held By Institutions
11.1M
Shares Outstanding - Current
45.5M
Total Liabilities
81.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-36.898
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
611 Gateway Boulevard
Phone
+1 415 910-5717
Employees
32
Web
https://www.quincetx.com